Maya Biotech Private Limited

Maya Biotech Private Limited - pharma in Chandigarh, India. FY 2026 financials & compliance.
CIN U55101CH1998PTC021391 Incorporated 15 May 1998 ROC Chandigarh HQ Chandigarh, India
Active Private Limited Company pharma MSME · Small
Revenue · FY 2024
₹42.5 Cr
▼ 3% YoY
Net profit · FY 2024
₹3.77 Cr
Net margin 8.9%
EBITDA · FY 2024
₹7.72 Cr
EBITDA margin 18.2%
Authorised capital
₹1.25 Cr
Registered with MCA
Paid-up capital
₹1.18 Cr
Issued & subscribed
Open charges
₹3.3 Cr
Satisfied ₹1.7 Cr
Company age
28 yrs
Est. 1998
Employees · EPFO
49
Provident fund records

About Maya Biotech Private Limited

Data last updated:

Maya Biotech Private Limited is a private limited company based in Chandigarh, India, a subsidiary of Mediaid Labs Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 May 1998 and has been in existence for over 28 years.

The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U55101CH1998PTC021391. Its GSTIN is 04AABCD3307M1ZX (Chandigarh).

The company has an authorised share capital of ₹1.25 Cr and a paid-up capital of ₹1.18 Cr. It was formerly known as Toshika Laboratories Private Limited and Drs Hotels Private Limited. It is led by directors Manoj Agarwal (Whole-Time Director) and Parth Agarwal.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No. 46 Ram Darbar Industrial Area Phase – 2, Chandigarh, India – 160002.

As per the financials filed for FY 2024, the company reported a revenue of ₹42.5 Cr, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹3.77 Cr (net margin 8.9%) and EBITDA of ₹7.72 Cr (EBITDA margin 18.2%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 17% over five years.

The company has about 49 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹3.3 Cr and satisfied charges of ₹1.7 Cr on record. Court records list 9 cases involving the company, including 4 filed by the company and 5 filed against it; 2 cases are pending. The company has 5 deals on record (3 funding rounds, 2 secondary share transfers), with disclosed funding of ₹1.16 Cr; the latest was in March 2013. Its 8 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 5 smaller; the largest is Legency Remedies Private Limited with revenue of ₹42.77 Cr.

Maya Biotech Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-11-0004972). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mayabiotechindia.com.

Company details

CIN U55101CH1998PTC021391
Registration Number 021391
Incorporation Date 15 May 1998
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Parent Company Mediaid Labs Private Limited
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-HP-11-0004972

Name history

Maya Biotech has undergone 2 name changes throughout its history. The company was previously known as Toshika Laboratories Private Limited, and Drs Hotels Private Limited. The current legal name is Maya Biotech Private Limited.

Company NameStatus
Maya Biotech Private LimitedCurrent
Toshika Laboratories Private LimitedPrevious
Drs Hotels Private LimitedPrevious

Recognitions & Rankings of Maya Biotech

MSME (Udyam registered) Ministry of MSME
Category
Small (2021-22)
Udyam number
UDYAM-HP-11-0004972

Contact details

Maya Biotech Private Limited's registered office is in Chandigarh, Chandigarh. Its website is mayabiotechindia.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Plot No. 46 Ram Darbar Industrial Area Phase – 2, Chandigarh, India – 160002
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Maya Biotech Private Limited, buy the company report.

Comprehensive company report
Maya Biotech Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Maya Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Maya Biotech Private Limited, buy the company report.

Financials of Maya Biotech Private Limited

FY 2024 filings available

Maya Biotech Private Limited reported revenue of ₹42.5 Cr (down 3% YoY) for FY 2024.

Revenue · FY 2024
₹42.5 Cr ▼ 3%
Net profit · FY 2024
₹3.77 Cr margin 8.9%
EBITDA · FY 2024
₹7.72 Cr margin 18.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 3%
3 years · compounded
▲ 7%
5 years · compounded
▲ 17%
EBITDA CAGR growth
1 year
▼ 18%
3 years · compounded
▲ 6%
5 years · compounded
▲ 28%

Revenue fell 3% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 17%. EBITDA fell 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations₹42.5 Cr
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹7.72 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹3.77 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin18.2%
Net Profit Margin8.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Maya Biotech Private Limited, buy the company report.

Board of directors of Maya Biotech Private Limited

Maya Biotech has 2 current directors and 21 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Manoj AgarwalWhole-Time Director14 May 201214 Years 6 MonthsCurrent
Parth AgarwalDirector10 Oct 20197 Years 1 MonthsCurrent

Peer comparison

Maya Biotech Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Legency Remedies Private Limited₹42.77 Cr (FY 2025)-11.0%Baddi, Himachal Pradesh, India
Brussels Laboratories Pvt Ltd₹42.73 Cr (FY 2025)7.0%Dist-Ahmedabad, Gujarat, India
La Chemico Pvt Ltd₹42.52 Cr (FY 2024)0.0%Kolkata, West Bengal, India
Maya Biotech Private Limitedthis company₹42.5 Cr (FY 2024)₹3.77 Cr8.9%-3.0%49Chandigarh, India
Base Medico Private Limited₹42.21 Cr (FY 2025)-12.0%Vadodara, Gujarat, India
Spectrum Formulation Private Limited₹42.18 Cr (FY 2025)23.0%Indore, Madhya Pradesh, India
Supercure Biotech Private Limited₹42.03 Cr (FY 2024)6.0%Delhi, India
International Ingredients & Excipients Private Limited₹41.96 Cr (FY 2025)58.0%Chennai, Tamil Nadu, India
Samrudh Pharmacare Private Limited₹41.88 Cr (FY 2024)-7.0%Mumbai, Maharashtra, India

To see the full peer comparison of Maya Biotech Private Limited, buy the company report.

Auditor

Maya Biotech Private Limited is audited by VIJAYANT GOYAL & ASSOCIATES for the financial year 2024.

Auditor firmFinancial yearFirm registration number
VIJAYANT GOYAL & ASSOCIATESFY 2024021943N

Shareholding

The shareholding of Maya Biotech Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Maya Biotech Private Limited, buy the company report.

Charges & borrowings

Open charges
₹3.3 Cr
Satisfied charges
₹1.7 Cr
Breakdown by lending institutions
Axis Bank Limited₹2.80 Cr
Others₹0.50 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
29 Aug 2024100977945Others₹50 LakhOpen
16 Feb 201310411862Axis Bank Limited₹1.9 CrOpen
02 Feb 201310408383Axis Bank Limited₹55 LakhOpen
02 Feb 201310409688Axis Bank Limited₹35 LakhOpen
30 May 201110288039Uco Bank₹1 CrSatisfied

To see the full charge records of Maya Biotech Private Limited, buy the company report.

Total charge records: 7 View all charges

Deals & funding

Maya Biotech Private Limited has 5 deals on record (3 funding rounds, 2 secondary share transfers), with disclosed funding of ₹1.16 Cr; the latest was in March 2013.

Total deals
5
Funding rounds
3
Secondary share transfers
2
Disclosed funding
₹1.16 Cr

Deals on record (5 of 5)

WhenDealAmountParties
Mar 2013Secondary share transferUndisclosedBuyer: Mediaid Labs Private Limited
Seller: 4 individuals
May 2012Funding round₹86.9 LakhInvestors: Mediaid Labs Private Limited , 3 individuals
May 2012Funding round₹16.3 LakhInvestors: Mediaid Labs Private Limited
Mar 2011Secondary share transferUndisclosedBuyer: 3 individuals
Seller: Devenderjit Singh Dhillon Huf, 3 individuals
Jun 2007Funding round₹13.2 LakhInvestors: Devenderjit Singh Dhillon Huf, 3 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Maya Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Maya Biotech Private Limited has a workforce of 49 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
49
Active EPFO establishments
1

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2749
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Maya Biotech Private Limited, buy the company report.

GST

Maya Biotech has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
04AABCD3307M1ZXChandigarhActive05 Sep 2021

To see the full GST registrations and return filing status of Maya Biotech Private Limited, buy the company report.

Recent activity

Maya Biotech Private Limited has 23 board changes on record since 2011: 2 appointments and 21 cessations. The latest: Parth Agarwal ceased to be Additional Director on 31 Dec 2020.

AGM
Maya Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 0.50 Cr with Charge ID 100977945 was registered on 29 Aug 2024.
Filing
Maya Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh.
Ceased
Parth Agarwal ceased to be Additional Director.
Appointed
Parth Agarwal was appointed as Director.
Ceased
Janki Ballabh Agarwal ceased to be Additional Director.
Ceased
Pudugrammam Krishna Iyer Vaidyanathan ceased to be Director.
Ceased
Gurmeet Singh Narula ceased to be Director.
Ceased
Parvinder Singh Gulati ceased to be Director.
Ceased
Manoj Agarwal ceased to be Additional Director.
Ceased
Sham Lal Singla ceased to be Additional Director.
Ceased
Amit Kumar ceased to be Additional Director.

25 earlier events are in the company report.

Frequently asked questions

Maya Biotech is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 May 1998 (28+ years old) and is registered under CIN U55101CH1998PTC021391.

Maya Biotech has 2 current directors:

The latest financial statements of Maya Biotech on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Maya Biotech is 04AABCD3307M1ZX, registered in Chandigarh.

The CIN (Corporate Identification Number) of Maya Biotech is U55101CH1998PTC021391. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Maya Biotech has 9 court cases on record: 4 filed by the company and 5 filed against it. 2 are pending.

Maya Biotech was incorporated on 15 May 1998, making it 28+ years old. It is registered with the Registrar of Companies, Chandigarh.

Maya Biotech has 5 deals on record (3 funding rounds, 2 secondary share transfers), with disclosed funding of ₹1.16 Cr; the latest was in March 2013.

The peers of Maya Biotech by revenue are Legency Remedies Private Limited, Brussels Laboratories Pvt Ltd, La Chemico Pvt Ltd, Base Medico Private Limited, Spectrum Formulation Private Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Parth Agarwal ceased to be Additional Director on 31 Dec 2020. Parth Agarwal was appointed as Director on 10 Oct 2019. Janki Ballabh Agarwal ceased to be Additional Director on 30 Sep 2019. Maya Biotech has 23 board changes on record in total.

Yes, Maya Biotech is registered as a small enterprise under Udyam registration (number: UDYAM-HP-11-0004972).